283 related articles for article (PubMed ID: 27259695)
1. Checkpoint Blockade - a New Treatment Paradigm in Renal Cell Carcinoma.
Grünwald V
Oncol Res Treat; 2016; 39(6):353-8. PubMed ID: 27259695
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy for Lung Cancer.
Reinmuth N; Reck M
Oncol Res Treat; 2016; 39(6):360-8. PubMed ID: 27259861
[TBL] [Abstract][Full Text] [Related]
3. Check point inhibitors a new era in renal cell carcinoma treatment.
Alsharedi M; Katz H
Med Oncol; 2018 May; 35(6):85. PubMed ID: 29728867
[TBL] [Abstract][Full Text] [Related]
4. Emerging immunotherapy in advanced renal cell carcinoma.
Mendiratta P; Rini BI; Ornstein MC
Urol Oncol; 2017 Dec; 35(12):687-693. PubMed ID: 28889919
[TBL] [Abstract][Full Text] [Related]
5. Novel immunotherapeutic strategies in development for renal cell carcinoma.
Inman BA; Harrison MR; George DJ
Eur Urol; 2013 May; 63(5):881-9. PubMed ID: 23084331
[TBL] [Abstract][Full Text] [Related]
6. Checkpoint inhibitors and other novel immunotherapies for advanced renal cell carcinoma.
Carlo MI; Voss MH; Motzer RJ
Nat Rev Urol; 2016 Jul; 13(7):420-31. PubMed ID: 27324121
[TBL] [Abstract][Full Text] [Related]
7. Advances in Cancer Therapy: Immunotherapies.
Marmé D
Oncol Res Treat; 2016; 39(6):324-5. PubMed ID: 27260772
[No Abstract] [Full Text] [Related]
8. Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?
Anselmo Da Costa I; Rausch S; Kruck S; Todenhöfer T; Stenzl A; Bedke J
Expert Rev Anticancer Ther; 2017 Apr; 17(4):357-368. PubMed ID: 28162024
[TBL] [Abstract][Full Text] [Related]
9. Immune checkpoint blockade as a novel immunotherapeutic strategy for renal cell carcinoma: a review of clinical trials.
Godwin JL; Zibelman M; Plimack ER; Geynisman DM
Discov Med; 2014 Dec; 18(101):341-50. PubMed ID: 25549705
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in renal cell cancer immunotherapy.
Wysocki PJ; Zolnierek J; Szczylik C; Mackiewicz A
Expert Opin Biol Ther; 2007 May; 7(5):727-37. PubMed ID: 17477809
[TBL] [Abstract][Full Text] [Related]
11. Immune Checkpoint Therapy in Renal Cell Carcinoma.
Lee CH; Motzer RJ
Cancer J; 2016; 22(2):92-5. PubMed ID: 27111903
[TBL] [Abstract][Full Text] [Related]
12. Immune checkpoint inhibitors as novel targets for renal cell carcinoma therapeutics.
Bailey A; McDermott DF
Cancer J; 2013; 19(4):348-52. PubMed ID: 23867517
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of Urological Cancer Patients With WT1 Peptide-Pulsed Dendritic Cells in Combination With Molecular Targeted Therapy or Conventional Chemotherapy Induces Immunological and Clinical Responses.
Ogasawara M; Miyashita M; Ota S
Ther Apher Dial; 2018 Jun; 22(3):266-277. PubMed ID: 29851270
[TBL] [Abstract][Full Text] [Related]
14. TroVax(®) vaccine therapy for renal cell carcinoma.
Zhang RT; Bines SD; Ruby C; Kaufman HL
Immunotherapy; 2012 Jan; 4(1):27-42. PubMed ID: 22149999
[TBL] [Abstract][Full Text] [Related]
15. [Immunotherapy for renal cell carcinoma - current status].
Grimm MO; Foller S
Aktuelle Urol; 2018 Apr; 49(2):187-191. PubMed ID: 29587324
[TBL] [Abstract][Full Text] [Related]
16. Current immunotherapeutic strategies in renal cell carcinoma.
Amato RJ
Surg Oncol Clin N Am; 2007 Oct; 16(4):975-86, xi-xii. PubMed ID: 18022554
[TBL] [Abstract][Full Text] [Related]
17. Current Immunotherapies for Renal Cell Carcinoma.
Al-Marrawi MY; Holder SL
Curr Mol Pharmacol; 2016; 9(3):252-263. PubMed ID: 26177641
[TBL] [Abstract][Full Text] [Related]
18. [The present state and the future perspective of immunotherapy of renal cell carcinoma].
Kawashima H
Nihon Rinsho; 2015 Jan; 73(1):167-74. PubMed ID: 25626324
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy for kidney cancer: status quo and the future.
Bedke J; Stühler V; Stenzl A; Brehmer B
Curr Opin Urol; 2018 Jan; 28(1):8-14. PubMed ID: 29120911
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of Melanoma.
Bender C; Hassel JC; Enk A
Oncol Res Treat; 2016; 39(6):369-76. PubMed ID: 27259558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]